|Articles|June 15, 2004

Topical cyclosporine can handle more than just dry eye disease

Any T cell-mediated disease found to benefit from this therapy without affecting other inflammatory pathways

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Latest CME